Genmab has achieved a third pre-clinical milestone that generates a payment worth €1m as part of a collaboration with Lundbeck. The deal allows Genmab, which received €7.5m upfront payment previously, to develop human ...
Tags: Genmab, clinical trial, cooperation
The USFDA has approved Novartis' Signifor (pasireotide) injection to treat Cushing's disease, an endocrine disorder. The only approved pituitary-directed therapy in the US, for the patients who are not suitable for pituitary surgery, ...
Tags: USFDA, Cushing's disease, clinical treatment
Name: Jon Brilliant Age: 48 Time with company: board of directors when founded, became CFO 3 years ago. Education: Bachelor's degree in accounting from The Pennsylvania State University and a graduate degree, Juris Doctor, from Duke ...
Tags: Jon Brilliant, CFO, Welldoc
The Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel has scheduled to review the data presented in the Second Sight Medical Products' humanitarian device exemption (HDE) market approval application, for its Argus II ...
Tags: FDA, Argus II System, medical technology
Avinger, a manufacturer of multi-functional catheters, has raised $33m in Series D financing round. The finance was raised based on the completion of the company's Connect II global clinical trial for Ocelot catheter, which is integrated ...
Tags: Avinger, multi-functional catheters, peripheral artery diseases
The Israel's Ministry of Health (MOH) has granted approval to Medgenics to initiate two Phase I/II clinical trials of a subcutaneous autologous tissue implant, INFRADURE, in patients with hepatitis C. The objective of the trials is to ...
Tags: MOH, clinical trial, medical research
Sunshine Heart has obtained a conditional approval from the US Food and Drug Administration (FDA) for its investigational device exemption (IDE)) implantable heart assist device. The non-blood contacting C-Pulse Heart Assist device, ...
Tags: C-Pulse IDE Device, FDA, clinical trial
Vascular Insights, a manufacturer of peripheral vascular devices, has started a multi-center dose-finding study of its non-thermal vein ablation ClariVein system, designed to treat venous reflux diseases. The ClariVein system uses ...
Tags: peripheral vascular device, clinical trial, clinical technology
SRS Medical, a provider of urology products, has purchased AbbeyMoor Medical's Spanner temporary prostatic stent. SRS Medical CEO Lee Brody said the Spanner is a synergistic addition to the company's suite of urology products for the ...
Tags: acquisition, urology product, clinical trial
Sunshine Heart is planning to initiate a US pivotal trial on its C-Pulse Heart Assist device in the fourth quarter of 2012, as it received an unconditional approval from the US Food Drug Administration (FDA). The CE marked system, ...
Tags: FDA, clinical trial, medical system
A new clinical study found that Bayer's blood glucose monitoring (BGM) system CONTOUR Next EZ meter and CONTOUR Next test strips proved easy to use and highly accurate when used by both patients and their healthcare professionals (HCPs). ...
Tags: medical system, clinical trial, blood glucose monitoring system
Allegro Diagnostics is set to present results of its BronchoGen genomic test, from Airway Epithelium Gene Expression In the Diagnosis of Lung Cancer (AEGIS) clinical trials, in a late-breaking abstract session at CHEST to be held on 23 ...
Medical diagnostic services provider CML HealthCare has entered into a license agreement to provide Mitomics' Prostate Core Mitomic test (PCMT) to urologists across Canada. Using the science of mitochondrial DNA analysis, the test ...
pSivida has completed enrolling first US patient in investigator-sponsored clinical trial of its injectable sustained release insert. pSivida president and CEO Ashton said the trial will study the use of injectable micro-inserts to treat ...
Tags: pSivida, clinical trial, injectable sustained release insert
Eastern Cooperative Oncology Group, now a part of the ECOG-ACRIN Cancer Research Group, has entered into an agreement to use Sequenta's new LymphoSIGHT sequencing method in its randomized E1411 phase II trial. LymphoSIGHT is designed for ...